![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Optibiotix Health Plc | LSE:OPTI | London | Ordinary Share | GB00BP0RTP38 | ORD 2P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.25 | 1.59% | 16.00 | 15.50 | 16.50 | 16.00 | 15.75 | 15.75 | 108,956 | 08:09:01 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Noncomml Resh Organizations | 457k | 2.59M | 0.0284 | 5.55 | 14.36M |
Date | Subject | Author | Discuss |
---|---|---|---|
31/10/2016 11:23 | Bit late with the chart again Missed the drop and Its already on the up (for the moment) | ![]() judijudi | |
31/10/2016 11:22 | I was away last week so missed the decline. Horizontal support at 63.00p remained intact (on a two day closing basis) and the share-price just touched the bottom of the descending channel - again. Closes above the recent high of 73.65p can be construed as a change in trend and would take us out of the descending channel. It would also give a double bottom. The 50 day SMA is at a smidge over 70.00p and has kept a lid on things since late June. The 200 day SMA is at 76.33p. Indicators are bullish. I'll do a chart later...just got busy elsewhere! M EDIT: A bit of a whoosh since I started typing!¬) | ![]() marnewton | |
31/10/2016 11:13 | IMHO combination of anticipation of news during the summit and no overhang of stock at present. | ![]() john henry | |
31/10/2016 11:07 | Wow...a vertical line just appeared on the graph....probably smaller than it first looks....but lovely!! | ![]() bobdown2 | |
31/10/2016 11:06 | Nice move. | ![]() someuwin | |
31/10/2016 11:06 | Is the rise today due to HSR update over the weekend? | mazzstar | |
31/10/2016 11:00 | Hopefully we can reach 73-75p and out of this obvious downtrend channel since June | ![]() onedayrodders | |
31/10/2016 10:55 | Price is now 68-70. Advfn needs to catch up! | ![]() parob | |
31/10/2016 10:55 | Plenty available if you go through a broker | ![]() judijudi | |
31/10/2016 10:49 | Might see the 70s before the end of play with a bit more volume. | ![]() rafboy | |
31/10/2016 10:38 | Can't buy many online | ![]() someuwin | |
31/10/2016 10:32 | Allot nicer today.. | ![]() bobdown2 | |
31/10/2016 08:56 | I have a gut feeling that we may see some kind of JV or commercial deal announcement to coincide with the Summit this week. contracts have been signed that pretty obvious from the update. | ![]() john henry | |
31/10/2016 08:48 | A little interest so far this morning. I am hoping that we can be back into the 70s by the end of the week. | ![]() rafboy | |
29/10/2016 15:30 | Similar to what Siennadelekat reports. Historically I suffered with heartburn, usually late evening. I hadn't given it a thought. I never really got to the bottom of why I suffered with it. It want poor eating habits. I had heartburn last night for the first time since using GF, which I know was caused by Budweiser out of a tin. Yuk. Never again. | elrico | |
29/10/2016 14:10 | We are told "The publication of results from our successful human cholesterol study and scientific studies demonstrating our products mechanism of action will support the launch of a range of cardiovascular products to reduce LDL cholesterol, blood pressure, and cardiovascular risk, anticipated for the spring of 2017. These studies, once published, provide the scientific evidence for sales and marketing literature to provide product differentiation and support higher margins." | ![]() nw99 | |
29/10/2016 13:45 | Great post and spot on mouse - Manchester United are rubbish! Parob - thanks for earlier shout on trialling go figure, Max is sending form out next week to see if I meet their requirements. | ![]() whl2 | |
29/10/2016 12:48 | Trademark LP-LDL hxxp://www.trademark On Monday, August 08, 2016, an european community trademark registration was filed for LPLDL by Optibiotix Limited Innovation Centre, Innovation Way, Heslington York GB YO10 5DG. The OHIM has given the trademark application number of 015734429. The current status of this trademark filing is Application published. The correspondent listed for LPLDL is APPLEYARD LEES IP LLP of 15 Clare Road, Halifax,, West Yorkshire GB HX1 2HY . The LPLDL trademark is filed in the category of Meats and Processed Food Products , Light Beverage Products , Pharmaceutical Products LPLDL Trademark Information Proteinaceous foodstuffs; proteinaceous preparations for human consumption; vitamin, protein and mineral enriched foods and foodstuffs; nutritional foodstuffs; dried milk-based products for meal replacements; dairy products; milk and milk products; yogurt; meat, fish, poultry and game products; meat extracts; preserved, frozen, dried and cooked fruits and vegetables; edible oils and fats.Non alcoholic beverages; preparations for making non-alcoholic beverages; nutritional and dietetic beverages; beverages containing nutritional supplements and preparations for making the same; isotonic beverages; drinks with added vitamin, mineral, protein and/or sugar concentrates; protein drinks; vitamin- and mineral-enriched drinks; powders and other preparations for making drinks.Pharmaceutica . | ![]() mouse20 | |
29/10/2016 10:50 | This week could finally be the week that OPTI hopefully finds some traction and support. | ![]() john henry | |
29/10/2016 10:06 | Global $2.2 Billion Microbiome Therapeutics and Diagnostics Pipeline Analysis and Market Outlook 2016-2025 - Research and Markets | maxwellsdemon | |
29/10/2016 09:57 | It's also worth noting that Isabelle de Cremoux - President & CEO of Seventure Partners will be speaking at the summit:"Seventure Partners is a Paris-based venture capital organization focused on innovation in life sciences and ICT. The broad focus areas within life sciences are therapeutics, medical devices and diagnostics and nutrition. The specific 'core' of Seventure's investment strategy is 'health, biotech, nutrition and wellness', with particular focus on the microbiome."It would be fantastic if Seventure started to acquire OPTI stock, if they haven't already. | ![]() parob | |
29/10/2016 09:34 | So here's what SOH will be speaking about at this week's upcoming summit:3. Targeted Microbiome Modulation: Next Generation Pre-, Pro-, and SynbioticsTo develop compounds to modulate the human microbiome. This is achieved by:-Its proprietary high throughput screening and optimisation Optiscreen® platform to identify microbial strains within the human microbiome with metabolic pathways which can interact with humanPhysiological processes and bring health benefitsIts proprietary OptiBiotic® platform technology which generates sugars from microbial strains. These sugars have the ability to accentuate the growth rate of specific microbialstrains, species, and genera.Stephen O'Hara - OptiBiotix Health -CEOIt's interesting to look around the agenda page - one speaker will talk about "Probiotics and prebiotics for mental health and cognition". | ![]() parob | |
28/10/2016 17:49 | mouse20, thanks for that : Canadian not Swedish mice becoming bolder etc.. As you say, all inconclusive at this stage - unless of course OPTI has a march ahead of everyone, per Parob's reminder above (16952). Given the unknown element that appears to surround the science - as elrico demonstrates with the PNSA paper which highlights the ill-defined way BSH's & bacteria interact - it's been interesting to hear if current users of the slimming product happen to observe any behavioural change aside from that associated with dieting itself.'More energy' sounds good of course. EDIT extra : elrico's paper was dated 2008 so maybe there've been advances since then re the role of bile salts etc. | ![]() dogwalker |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions